Business ❯Healthcare ❯Pharmaceuticals

Cancer Treatment

Bispecific Antibodies Summit Therapeutics Keytruda

Bristol Myers Squibb to Acquire 2seventy Bio in $286 Million Deal

Merck's Q3 Earnings Exceed Expectations Despite Gardasil Sales Slump in China